眾安提高疫苗副作用保障授助金額至每日1,000元 撤名額限制
眾安國際宣布提高「新冠疫苗副作用保障」的住院現金援助金額,並取消名額限制,新安排下,如ZA Fam會員在接種由香港政府認可的新型冠狀病毒疫苗後14天內因副作用而入院治療,每日可獲現金援助金額將由800元提升至1,000元,受保障住院時間亦由10日增長至15日。一旦會員不幸因疫苗副作用而身故,計劃會為其提供一筆過20萬的身故恩恤金。另外,計劃將取消名額限制,希望能讓更多有需要的社群受惠。
「ZA 抗疫保障金」的有效期至6月30日,凡持有有效香港身份證的香港居民,無論是新加入或現有的ZA Fam會員,均可免費參加計劃 。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.